mn€ | notes | 2023 | 2022 |
Revenues | 1 | ||
Other operating revenues | 2 | ||
Raw and other materials | 3 | ( | ( |
Service costs | 4 | ( | ( |
Personnel costs | 5 | ( | ( |
Other operating expenses | 6 | ( | ( |
Capitalised costs | 7 | ||
Amortisation, provisions and depreciation | 8 | ( | ( |
Operating profit | |||
Share of profits (losses) pertaining to joint ventures and associated companies | 9 | ||
Financial income | 10 | ||
Financial expenses | 11 | ( | ( |
Financial operations | ( | ( | |
Earnings before taxes | |||
Taxes | 12 | ( | ( |
Net profit for the period | |||
Attributable to: | |||
parent company shareholders | |||
non-controlling interests | |||
Earnings per share | |||
basic | 17 | ||
diluted | 17 |
mn€ | notes | 2023 | 2022 |
Net profit (loss) for the period | |||
Items reclassifiable to the income statement | |||
Fair value of derivatives, change for the period | 29 | ( | |
Tax effect related to reclassifiable items | ( | ||
Items not reclassifiable to the income statement | |||
Actuarial income (losses) employee and post-employment | 30 | ( | |
benefits | |||
Shareholdings valued at fair value | 26 | ( | |
Tax effect related to not reclassifiable items | ( | ||
Total comprehensive profit (loss) for the period | |||
Attributable to: | |||
Parent company shareholders | |||
non-controlling interests |
mn€ | notes | 31 Dec 23 | 31 Dec 22 |
ASSETS | |||
Non-current assets | |||
Tangible assets | 21,25 | ||
Rights of use | 22,25 | ||
Intangible assets | 23,25 | ||
Goodwill | 24,25 | ||
Shareholdings | 26,27 | ||
Non-current financial assets | 18 | ||
Deferred tax assets | 14 | ||
Derivative instruments | 29 | ||
Total non-current assets | |||
Current assets | |||
Inventories | 32 | ||
Trade receivables | 33 | ||
Current financial assets | 18 | ||
Current tax assets | 13 | ||
Other current assets | 35 | ||
Derivative instruments | 29 | ||
Cash and cash equivalents | 18 | ||
Total current assets | |||
TOTAL ASSETS |
notes | 31 Dec 23 | 31 Dec 22 | |
NET EQUITY AND LIABILITIES | |||
Share capital and reserves | |||
Share capital | 15 | ||
Reserves | 15 | ||
Profit (loss) for the period | 15 | ||
Group net equity | |||
Non-controlling interests | 16 | ||
Total net equity | |||
Non-current liabilities | |||
Non-current financial liabilities | 19 | ||
Non-current lease liabilities | 22 | ||
Post-employment and other benefits | 30 | ||
Provisions for risks and charges | 31 | ||
Deferred tax liabilities | 14 | ||
Derivative instruments | 29 | ||
Total non-current liabilities | |||
Current liabilities | |||
Current financial liabilities | 19 | ||
Current lease liabilities | 22 | ||
Trade payables | 34 | ||
Current tax liabilities | 13 | ||
Other current liabilities | 36 | ||
Derivative instruments | 29 | ||
Total current liabilities | |||
TOTAL LIABILITIES | |||
TOTAL NET EQUITY AND LIABILITIES |
mn€ | notes | 31 Dec 23 | 31 Dec 22 |
Earnings before taxes | |||
Adjustments to reconcile net profit to cash flow from operating activities | |||
Amortisation and impairment of assets | 8 | ||
Allocation to provisions | 8 | ||
Effects from valuation using the net equity method | 9 | ( | ( |
Financial (income) expenses | 10,11 | ||
(Capital gains) losses and other non-monetary elements | ( | ||
Change in provision for risks and charges | 31 | ( | ( |
Change in provision for employee and post-employment benefits | 30 | ( | ( |
Total cash flow before changes in net working capital | |||
(Increase) decrease in inventories | 37 | ( | |
(Increase) decrease in trade receivables | 37 | ( | ( |
Increase (decrease) in trade payables | 37 | ( | |
Increase/decrease in other current assets/liabilities | 37 | ||
Changes in working capital | ( | ||
Dividends collected | 37 | ||
Interest income and other financial income collected | 37 | ||
Interest expenses, net charges on derivatives and other financial charges paid | 37 | ( | ( |
Taxes paid | 37 | ( | ( |
Cash flow from operating activities (a) | |||
Investments in tangible assets | 21 | ( | ( |
Investments in intangible assets | 23 | ( | ( |
Investments in subsidiary companies and business units net of cash holdings | 28 | ( | ( |
Other equity investments | 28 | ( | |
Sale price of tangible and intangible assets | |||
(Increase) decrease in other investment activities | 28 | ||
Cash flow from (for) investing activities (b) | ( | ( | |
New issue of long-term bonds | 20 | ||
Repayments of non-current financial liabilities | 20 | ( | |
Repayments and other net changes in financial liabilities | 20 | ( | ( |
Repayments of leasing liabilities | 20 | ( | ( |
Acquisition of interests in consolidated companies | 20 | ( | ( |
Increase in minority share capital | 20 | ||
Dividends paid out to Hera shareholders and non-controlling interests | 20 | ( | ( |
Changes in treasury shares | 15 | ( | ( |
Cash flow from (for) financing activities (c) | ( | ||
Increase (decrease) in cash holdings (a+b+c) | ( | ||
Cash and cash equivalents at the beginning of the period | 18 | ||
Cash and cash equivalents at the end of the period | 18 |
Reserves | Reserves | ||||||||
Reserves | actuarial | share- | Non- | ||||||
mn€ | Share | Reserves | derivatives | income | holdings | Profit for | Net equity controlling | Total | |
capital | valued at | (losses) | valued at fair | the period | interests | ||||
fair value | employee | value | |||||||
benefits | |||||||||
Balance at 1 Jan 22 | ( | ( | |||||||
Profit for the period | |||||||||
Other components of comprehensive income: | |||||||||
fair value of derivatives, change for the period | |||||||||
actuarial income (losses) | |||||||||
employee and post- employment benefits | |||||||||
fair value of shareholdings, change for the period | ( | ( | ( | ||||||
Overall profit for the period | ( | ||||||||
change in treasury shares | ( | ( | ( | ( | |||||
change in equity | ( | ( | ( | ( | |||||
investments | |||||||||
other movements | ( | ||||||||
Allocation of revenues: | |||||||||
dividends paid out | ( | ( | ( | ( | |||||
allocation to reserves | ( | ||||||||
Balance at 31 Dec 22 | ( | ( | |||||||
Balance at 1 Jan 23 | ( | ( | |||||||
Profit for the period | |||||||||
Other components of comprehensive income: | |||||||||
fair value of derivatives, change for the period | ( | ( | ( | ||||||
actuarial income (losses) | ( | ( | ( | ( | |||||
employee benefit reserves | |||||||||
fair value of shareholdings, change for the period | |||||||||
Overall profit for the period | ( | ( | |||||||
change in treasury shares | ( | ( | ( | ( | |||||
minority share payments | |||||||||
change in equity | ( | ( | |||||||
investments | |||||||||
changes in scope of consolidation | |||||||||
other movements | ( | ( | ( | ( | |||||
Allocation of revenues: | |||||||||
dividends paid out | ( | ( | ( | ( | |||||
allocation to reserves | ( | ||||||||
Balance at 31 Dec 23 | ( | ( |